News
A new study suggests that hormone therapy, often used to ease symptoms of menopause like hot flashes and night sweats, may ...
Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.
A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...
The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...
On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...
An article in The Journal For Nurse Practitioners found that Depo-Testosterone was the most cost-efficient TRT option, and ...
22h
Axios on MSNFDA panel backs menopausal hormone therapyAn Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...
( NewsNation) — The head of the U.S. Food and Drug Administration signaled Thursday that he supports changing or removing the warnings printed on hormone replacement therapy products for menopausal ...
US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results